Literature DB >> 526888

Silver-resistant Enterobacteriaceae from hospital patients.

A T Hendry, I O Stewart.   

Abstract

The inclusion of agar medium containing 0.5 mM AgNO3 in the hospital laboratory replicating system for routine antibiotic-susceptibility determinations resulted in identification of species of Enterobacteriaceae (Escherichia coli, Enterobacter cloacae, Klebsiella pneumoniae, Proteus mirabilis, and Citrobacter freundii) with silver resistance. Since the study began in October, 1975, 11 in-hospital patients receiving silver sulfadiazine for burn wound prophylaxis have yielded silver-resistant bacteria from their infected burns. During this treatment routine burn-site cultures from these patients yielded 230 isolates of Enterobacteriaceae, including 211 which were sulfonamide-resistant, 97 of which were also silver-resistant, and 38 of which were untested for silver resistance. Seven silver-resistant but sulfonamide-sensitive isolates were incidentally recovered from respiratory specimens from four nonburn patients with silver tracheostomy tubes, one silver-resistant sulfonamide-sensitive isolate was recovered from a small infected burn on the foot of an Emergency Room patient. Previous treatment of this burn was unknown. Representative AgNO3-resistant E. coli isolates from four patients were serologically untypable. Serotyping of representative isolates of K. pneumoniae showed a diversity of types except from two patients who had been in the same ward at the same time.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 526888     DOI: 10.1139/m79-136

Source DB:  PubMed          Journal:  Can J Microbiol        ISSN: 0008-4166            Impact factor:   2.419


  24 in total

1.  Synthesis, characterization, and antimicrobial activity of silver carbene complexes derived from 4,5,6,7-tetrachlorobenzimidazole against antibiotic resistant bacteria.

Authors:  Brian D Wright; Parth N Shah; Lucas J McDonald; Michael L Shaeffer; Patrick O Wagers; Matthew J Panzner; Justin Smolen; Jasur Tagaev; Claire A Tessier; Carolyn L Cannon; Wiley J Youngs
Journal:  Dalton Trans       Date:  2012-03-08       Impact factor: 4.390

2.  Silver-resistant mutants of Escherichia coli display active efflux of Ag+ and are deficient in porins.

Authors:  X Z Li; H Nikaido; K E Williams
Journal:  J Bacteriol       Date:  1997-10       Impact factor: 3.490

Review 3.  The safety and efficacy of dressings with silver - addressing clinical concerns.

Authors:  Keith Cutting; Richard White; Mike Edmonds
Journal:  Int Wound J       Date:  2007-06       Impact factor: 3.315

4.  Heavy metal resistance in clinical isolates of Pseudomonas aeruginosa.

Authors:  R Vasishta; S Chhibber; M Saxena
Journal:  Folia Microbiol (Praha)       Date:  1989       Impact factor: 2.099

5.  Mechanism of resistance to silver ions in Klebsiella pneumoniae.

Authors:  P Kaur; D V Vadehra
Journal:  Antimicrob Agents Chemother       Date:  1986-01       Impact factor: 5.191

Review 6.  Silver as biocides in burn and wound dressings and bacterial resistance to silver compounds.

Authors:  Simon Silver; Le T Phung; Gregg Silver
Journal:  J Ind Microbiol Biotechnol       Date:  2006-05-25       Impact factor: 3.346

7.  Mobilization of Escherichia coli R1 silver-resistance plasmid pJT1 by Tn5-Mob into Escherichia coli C600.

Authors:  M E Starodub; J T Trevors
Journal:  Biol Met       Date:  1990

8.  Subtractive hybridization yields a silver resistance determinant unique to nosocomial pathogens in the Enterobacter cloacae complex.

Authors:  Anita N Kremer; Harald Hoffmann
Journal:  J Clin Microbiol       Date:  2012-07-25       Impact factor: 5.948

9.  Silver accumulation in Pseudomonas stutzeri AG259.

Authors:  G M Gadd; O S Laurence; P A Briscoe; J T Trevors
Journal:  Biol Met       Date:  1989

10.  Preventing Implant-Associated Infections by Silver Coating.

Authors:  Richard Kuehl; Priscilla S Brunetto; Anne-Kathrin Woischnig; Massimo Varisco; Zarko Rajacic; Juerg Vosbeck; Luigi Terracciano; Katharina M Fromm; Nina Khanna
Journal:  Antimicrob Agents Chemother       Date:  2016-03-25       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.